Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice

Aliabadi, 2016, Enterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014, Emerg. Infect. Dis., 22, 1387, 10.3201/eid2208.151949 Banna, 2004, Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy, Scand. J. Infect. Dis., 36, 155, 10.1080/00365540410019282 Bates, 2004, The use and misuse of Penh in animal models of lung disease, Am. J. Respir. Cell Mol. Biol., 31, 373, 10.1165/ajrcmb.31.3.1 van den Broek, 1995, Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors, J. Virol., 69, 4792, 10.1128/JVI.69.8.4792-4796.1995 Caliguiri, 1968, Action of guanidine on the replication of poliovirus RNA, Virology, 35, 408, 10.1016/0042-6822(68)90219-5 Centers for Disease Control and Prevention (CDC), 2011, Clusters of acute respiratory illness associated with human enterovirus 68—Asia, Europe, and United States, 2008–2010, MMWR Morb. Mortal. Wkly. Rep., 60, 1301 Control CfD, July 19, 2016 2017. Enterovirus D68. 〈https://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html〉. (Accessed 22 May 2017). Crone, 2016, Polio-like illness associated with outbreak of upper respiratory tract infection in children, J. Child Neurol., 31, 409, 10.1177/0883073815596613 Eggers, 1976, Successful treatment of enterovirus-infected mice by 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine, J. Exp. Med., 143, 1367, 10.1084/jem.143.6.1367 Esposito, 2015, Enterovirus D68 infection, Viruses, 7, 6043, 10.3390/v7112925 Esposito, 2017, Acute flaccid myelitis associated with enterovirus-D68 infection in an otherwise healthy child, Virol. J., 14, 4, 10.1186/s12985-016-0678-0 Evans W.J., Hurst, B.L., Peterson, C.J., Van Wettere, A., Day, C.W., Smee, D.F., Tarbet, E.B. Development of a Respiratory Disease Model for Enterovirus D68 in 4-Week-Old Mice for Evaluation of Antiviral Therapies (manuscript submitted for publication). Gowen, 2010, Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog, PLoS One, 5, e12760, 10.1371/journal.pone.0012760 Greninger, 2015, A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study, Lancet Infect. Dis., 15, 671, 10.1016/S1473-3099(15)70093-9 Hatzipetros, 2015, A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS, J. Vis. Exp., 10.3791/53257 Hibino, 2017, Interstitial pneumonia associated with the influenza vaccine: a report of two cases, Intern. Med., 56, 197, 10.2169/internalmedicine.56.7239 Hixon, 2017, A mouse model of paralytic myelitis caused by enterovirus D68, PLoS Pathog., 13, e1006199, 10.1371/journal.ppat.1006199 Hixon, 2017, Evaluating treatment efficacy in a mouse model of enterovirus D68-associated paralytic myelitis, J. Infect. Dis., 216, 1245, 10.1093/infdis/jix468 Hovden, 2015, Electrodiagnostic findings in acute flaccid myelitis related to enterovirus D68, Muscle Nerve, 52, 909, 10.1002/mus.24738 Imakita, 2000, Pneumonia caused by rhinovirus, Clin. Infect. Dis., 30, 611, 10.1086/313723 Imamura, 2015, Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections, Rev. Med. Virol., 25, 102, 10.1002/rmv.1820 Jacobs, 2013, Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients, Transpl. Infect. Dis., 15, 474 Julander, 2017, Small-animal models of Zika Virus, Infect. Dis., 216, S919, 10.1093/infdis/jix465 Julander, 2011, Important advances in the field of anti-dengue virus research, Antivir. Chem. Chemother., 21, 105, 10.3851/IMP1690 Lambert, 1966, Defects of neuromuscular transmission in syndromes other than myasthenia gravis, Ann. N.Y. Acad. Sci., 135, 367, 10.1111/j.1749-6632.1966.tb45484.x Lang, 2014, Acute flaccid paralysis following enterovirus D68 associated pneumonia, France, 2014, Eur. Surveill., 19, 10.2807/1560-7917.ES2014.19.44.20952 Lindquist, 2011, Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine, Neuropsychiatr. Dis. Treat., 7, 341 Lomask, 2006, Further exploration of the Penh parameter, Exp. Toxicol. Pathol., 57, 13, 10.1016/j.etp.2006.02.014 Lundblad, 2007, Penh is not a measure of airway resistance!, Eur. Respir. J., 30, 805, 10.1183/09031936.00091307 Maloney, 2015, MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak, AJNR Am. J. Neuroradiol., 36, 245, 10.3174/ajnr.A4188 Menachery, 2015, New metrics for evaluating viral respiratory pathogenesis, PLoS One, 10, e0131451, 10.1371/journal.pone.0131451 Messacar, 2015, A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA, Lancet, 385, 1662, 10.1016/S0140-6736(14)62457-0 Messacar, 2016, 2014 outbreak of enterovirus D68 in North America, J. Med. Virol., 88, 739, 10.1002/jmv.24410 Messacar, 2016, Resource burden during the 2014 Enterovirus D68 respiratory disease outbreak at Children's Hospital Colorado: an unexpected strain, JAMA Pediatr., 170, 294, 10.1001/jamapediatrics.2015.3879 Midgley, 2014, Severe respiratory illness associated with enterovirus D68— Missouri and Illinois, 2014, MMWR Morb. Mortal. Wkly. Rep., 63, 798 Mirand, 2015, Acute flaccid myelitis and enteroviruses: an ongoing story, Lancet, 385, 1601, 10.1016/S0140-6736(15)60121-0 Morrey, 2018, Causation of acute flaccid paralysis by myelitis and myositis in enterovirus-D68 infected mice deficient in interferon alphabeta/gamma receptors, Viruses, 10, 10.3390/v10010033 Muller, 1994, Functional role of type I and type II interferons in antiviral defense, Science, 264, 1918, 10.1126/science.8009221 National Research Council (U.S.), 2011. Committe for the Update of the Guide for the Care and Use of Laboratory Animals IfLARUS, National Academies Press (U.S.). Guide for the care and use of Laboratory Animals National Academies Press. Nelson, 2016, Recognition and management of acute flaccid myelitis in children, Pediatr. Neurol., 55, 17, 10.1016/j.pediatrneurol.2015.10.007 Peterson C.J., Hurst, B.L., Evans, W.J., Smee, D.F., Tarbet E.B., 2018. Evaluation of human intravenous immunoglobulin in disease models of EV-D68 and EV-71 infections in mice (manuscript submitted for publication). Pfeiffer, 2015, Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014, Eur. Surveill., 20, 21062, 10.2807/1560-7917.ES2015.20.10.21062 Reed, 1938, A simple method of estimating fifty percent endpoints, Am. J. Hyg., 27, 493 Rui, 2017, Disruption of MDA5-mediated innate immune responses by the 3C proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68, J. Virol., 91, 10.1128/JVI.00546-17 Sadeghipour, 2012, Selection and characterisation of guanidine-resistant mutants of human enterovirus 71, Virus Res., 169, 72, 10.1016/j.virusres.2012.07.005 Sarathy, 2015, Mouse models of dengue virus infection for vaccine testing, Vaccine, 33, 7051, 10.1016/j.vaccine.2015.09.112 Sidwell, 1972, Broad-spectrum antiviral activity of Virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide, Science, 177, 705, 10.1126/science.177.4050.705 Sidwell, 1992, Suppression of murine retroviral disease by 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T), Antivir. Res., 19, 313, 10.1016/0166-3542(92)90012-T Sidwell, 1998, Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor, Antivir. Res., 37, 107, 10.1016/S0166-3542(97)00065-X Sidwell, 2007, Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice, Antimicrob. Agents Chemother., 51, 845, 10.1128/AAC.01051-06 Smee, 2001, Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities, Antimicrob. Agents Chemother., 45, 743, 10.1128/AAC.45.3.743-748.2001 Smee, 2016, Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds, Antivir. Res., 131, 61, 10.1016/j.antiviral.2016.04.003 Tangermann, 2017, The critical role of acute flaccid paralysis surveillance in the Global Polio Eradication Initiative, Int. Health, 9, 156, 10.1093/inthealth/ihx016 Varghese, 2015, Sampling the upper respiratory tract for enteroviral infection is important in the investigation of an acute neurological illness in children, Eur. J. Paediatr. Neurol., 19, 494, 10.1016/j.ejpn.2015.03.009 Williams, 2016, Cluster of atypical adult Guillain-Barre syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016, Eur. Surveill., 21 2003 Xiang, 2014, Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3, J. Virol., 88, 6650, 10.1128/JVI.03138-13 Xiang, 2015, 3C Protease of Enterovirus D68 inhibits cellular defense mediated by interferon regulatory factor 7, J. Virol., 90, 1613, 10.1128/JVI.02395-15 Yea, 2017, Longitudinal outcomes in the 2014 acute flaccid paralysis cluster in Canada, J. Child Neurol., 32, 301, 10.1177/0883073816680770